Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
296 studies found for:    Hypertonia
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Use of EMG to Assess Clinical Hypertonia
Conditions: Cerebral Palsy;   Hypertonia;   Spasticity;   Dystonia;   Rigidity
Intervention: Device: portable surface electromyography
2 Completed Quantification of Upper Extremity Hypertonia
Conditions: Dystonia;   Muscle Hypertonia
Intervention:
3 Completed Hypertonia in Patients With Cerebral Palsy
Conditions: Cerebral Palsy;   Muscle Hypertonia
Intervention:
4 Unknown  Exploring Hypertonia in Children With Cerebral Palsy
Condition: Cerebral Palsy.
Intervention: Other: No intervention applicable
5 Recruiting Assessment of the Efficacy of a Sensorimotor Approach After Maximum Three Sessions in Subjects With TMD With Hypertonia
Condition: Temporomandibular Disorder
Intervention: Behavioral: Sensorimotor education with a view to obtaining an optimal FWS further to the relaxation of the masticatory, lingual and labial system. Learning of mandibular micro-movements in 5 directions.
6 Terminated Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured Patients
Conditions: Traumatic Brain Injury;   Cerebral Anoxia;   Coma;   Hypertonia;   Dysautonomia
Intervention: Drug: baclofen (drug)
7 Unknown  Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia
Condition: Hypertonia
Intervention:
8 Completed An Observational Study to Examine the Patients With Isolated Systolic Hypertonia (ISH) Under Therapy With Eneas® (NIS ENEAS ISH)
Condition: Hypertension
Intervention: Drug: Enalapril maleate (10 mg) + nitrendipine (20 mg)
9 Unknown  Impact of Listening to Low Tones on Motor Function in Children With CP
Conditions: Cerebral Palsy;   Hypertonia
Intervention: Behavioral: listening to music / stories via stereophonic headphones
10 Completed The Effects of Continuous Passive Motion on Hypertonia of Soleus in Individuals With Cerebral Palsy
Condition: Cerebral Palsy (CP)
Intervention: Procedure: Ankle continuous passive motion machine.
11 Completed Effects of DNHS Technique in the Treatment of Upper Limb Spasticity and Function in Stroke
Conditions: Stroke;   Spasticity
Interventions: Device: DNHS ® (Dry Needling for Hypertonia and Spasticity);   Device: Sham Dry Needling
12 Completed Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects
Condition: Dystonia
Intervention: Drug: trihexyphenidyl
13 Recruiting Surface EMG Biofeedback for Children With Cerebral Palsy
Conditions: Cerebral Palsy;   Dystonia;   Hypertonia;   Spasticity;   Movement Disorders
Intervention: Device: Sanger EMG Biofeedback Device
14 Completed MyoSense- Automated Muscle Hypertonicity Classification System
Conditions: Stroke;   Dystonia;   Cerebral Palsy
Intervention:
15 Terminated Improvement After Botulinum Toxin Injections to the Arms in Children With Cerebral Palsy
Condition: Cerebral Palsy
Interventions: Other: physiotherapy;   Other: Botulinum Toxin A and physiotherapy
16 Not yet recruiting Effects of Long-term Foam Rolling Compared to Static Stretching on Hamstring Muscle Flexibility
Condition: Muscle Hypertonia
Interventions: Other: Foam Rolling;   Other: Static Stretching
17 Completed Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy
Conditions: Cerebral Palsy;   Weakness;   Hypertonia
Intervention: Device: surface EMG biofeedback
18 Not yet recruiting ASIS for Botox in Upper Limb Spasticity
Conditions: Upper Limb Spasticity Unilaterally in Adults With History of Stroke;   Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12,;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally
19 Completed Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device
Condition: Upper Limb Spasticity
Intervention: Device: Treatment with Cryo-Touch III device
20 Active, not recruiting SISTERS: Spasticity In Stroke Study - Randomized Study
Condition: Severe Spasticity
Intervention: Drug: intrathecal baclofen

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years